Advertisement
For patients with Lynch syndrome

Aspirin Tied to Lasting Reduction in CRC Risk in Lynch Syndrome

0
Reduced risk for colorectal cancer seen in intention-to-treat and per-protocol analyses
Outpatients with bipolar disorder often have familial psychiatric history

Familial Psychiatric History Common in Bipolar Disorder

0
Patients with versus without familial history tend to need more treatment but have similar response
With most state reopenings well underway

COVID-19 Cases Rising in Many States as Reopening Continues

0
25,000 complaints filed against businesses in Manhattan and elsewhere for violating reopening plan
Black Americans are much more likely than other Americans to say a relative or close friend has died of COVID-19

Black Americans Much More Likely to Have Lost Loved Ones to COVID-19

0
11 percent of black adults say someone close to them has died; rates are 5 percent among Americans overall
The U.S. Food and Drug Administration has withdrawn its emergency authorization for the use of chloroquine phosphate and hydroxychloroquine sulfate in the fight against COVID-19.

FDA Pulls Emergency Approval of Hydroxychloroquine for COVID-19

0
Agency now says the drugs should not be used outside of clinical trials
Many clinical trials for COVID-19 treatments are limited by their design

Many of the Initial COVID-19 Treatment Trials Poorly Designed

0
One-third of trials do not include clinical end points; 97 randomized trials were open-label design
Oral polio vaccines might provide temporary protection against the new coronavirus while scientists try to develop a vaccine to fight COVID-19 infection

Oral Polio Vaccines Might Protect Against New Coronavirus

0
Since poliovirus and coronavirus are positive-strand RNA viruses, they may induce common innate immunity mechanisms
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of June 8 to 12

Physician’s Briefing Weekly Coronavirus Roundup

0
Here is what the editors at Physician's Briefing chose as the most important COVID-19 developments for you and your practice for the week of...
For patients with severe COVID-19

Acalabrutinib Promising for Treatment of Severe COVID-19

0
Selective bruton tyrosine kinase inhibitor treatment may improve oxygenation, reduce inflammation
In a joint position statement from seven leading diabetes organizations

Joint Framework Issued to Spur Diabetes Education, Support

0
Seven diabetes organizations issue guidance for diabetes self-management education and support